| Drug Name: | Cholestyramine (11041-12-6) |
|---|---|
| PubChem ID: | |
| SMILES: | CCC1=CC=C(C=C1)C(C)CCC2=CC=C(C=C2)[N+](C)(C)C |
| InchiKey: | HGMSJMJPXGGEBP-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 296.478 |
| LogP | : | 5.182 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 0 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 0 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Valproic Acid (99-66-1) | Valproate Auc Fell By 15% And The Maximum Serum Levels Fell By 21% | Antagonistic | Colestyramine is an ion-exchange resin intended to bind with bile acids in the gut, but it can also bind with drugs as well, leading to a reduction in their absorption | Effect of cholestyramine resin on single dose valproate pharmacokinetics |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category